BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 26231080)

  • 21. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
    Kamal A; Rao AV; Nayak VL; Reddy NV; Swapna K; Ramakrishna G; Alvala M
    Org Biomol Chem; 2014 Dec; 12(48):9864-80. PubMed ID: 25354805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
    Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
    Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption.
    Yugandhar D; Nayak VL; Archana S; Shekar KC; Srivastava AK
    Eur J Med Chem; 2015 Aug; 101():348-57. PubMed ID: 26163220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
    Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
    Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
    Liang Y; Zhou Y; Deng S; Chen T
    ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
    Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
    Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
    Harras MF; Sabour R
    Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of (Z)-(arylamino)-pyrazolyl/isoxazolyl-2-propenones as tubulin targeting anticancer agents and apoptotic inducers.
    Kamal A; Reddy VS; Shaik AB; Kumar GB; Vishnuvardhan MV; Polepalli S; Jain N
    Org Biomol Chem; 2015 Mar; 13(11):3416-31. PubMed ID: 25661328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis.
    Wang H; Zheng J; Xu W; Chen C; Wei D; Ni W; Pan Y
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28961210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles: exhibiting anticancer activity through intracellular ROS scavenging and the mitochondria-dependent death pathway.
    Alex JM; Singh S; Kumar R
    Arch Pharm (Weinheim); 2014 Oct; 347(10):717-27. PubMed ID: 25139842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors.
    Galal SA; Khairat SHM; Ali HI; Shouman SA; Attia YM; Ali MM; Mahmoud AE; Abdel-Halim AH; Fyiad AA; Tabll A; El-Shenawy R; El Abd YS; Ramdan R; El Diwani HI
    Eur J Med Chem; 2018 Jan; 144():859-873. PubMed ID: 29316526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on MCF-7 breast cancer cells by inhibiting tubulin polymerization.
    Wang G; Liu W; Peng Z; Huang Y; Gong Z; Li Y
    Bioorg Chem; 2020 Oct; 103():104141. PubMed ID: 32750611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
    Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one structural derivatives as anti-cancer and apoptosis inducing agents.
    Praveen Kumar C; Reddy TS; Mainkar PS; Bansal V; Shukla R; Chandrasekhar S; Hügel HM
    Eur J Med Chem; 2016 Jan; 108():674-686. PubMed ID: 26735909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
    Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
    Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
    Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluations of chirally pure 1,2,3,4-tertrahydroisoquinoline analogs as anti-cancer agents.
    Ramanivas T; Sushma B; Nayak VL; Chandra Shekar K; Srivastava AK
    Eur J Med Chem; 2015 Mar; 92():608-18. PubMed ID: 25615796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.